Different treatment outcomes in Gaucher disease type 1: case studies

Sinchuk, N. I.; Dudnyk, V. M.

dc.contributor.author	Sinchuk, N. I.	en
dc.contributor.author	Dudnyk, V. M.	en
dc.date.accessioned	2022-11-14T12:33:39Z
dc.date.available	2022-11-14T12:33:39Z
dc.date.issued	2021
dc.identifier.citation	Sinchuk N. I. Different treatment outcomes in Gaucher disease type 1: case studies / N. I. Sinchuk, V. M. Dudnyk // Cogent Medicine. - 2021. - № 8. - P. 160-161.	en
dc.identifier.uri	https://dspace.vnmu.edu.ua/123456789/5799
dc.description.abstract	The initial diagnosis of Gaucher disease (GD) is based on the β-glucosidase enzyme activity. However, similar levels of enzymes are not a predictor of treatment outcomes in different patients.	uk_UA
dc.language.iso	en	en
dc.publisher	Cogent Medicine	en
dc.title	Different treatment outcomes in Gaucher disease type 1: case studies	en
dc.type	Article	en